AstraZeneca has decided to abandon the pledge of not-for profit made during the pandemic and aims to make a modest profit from COVID-19 vaccinations.
Green light for small cell lung cancer treatment given to AstraZeneca in China
Based on positive results in a phase III trial, Imfinzi demonstrated improvement over chemotherapy alone, the approval was granted
Shard Capital: Insights into the small pharmaceutical company sector (video)
Wealth Manager at Shard Capital Stockbrokers, Simon Niven, provides some insights into the small pharmaceutical company sector.